# Sprott Physical Gold & Silver Trust: financial statements, quarterly

CEF · NYSE · CIK 1726122 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/cef.md) · [Financials](/companies/cef/financials.md) · [Filings](/companies/cef/filings.md) · [Insiders](/companies/cef/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/cef/financials.md?period=annual).

## Balance sheet

| Line item | Unit | period not labelled (2017-10-26) | period not labelled (2017-12-31) | FY2018 (2018-12-31) | FY2019 (2019-12-31) | FY2020 (2020-12-31) | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | not reported | [0.0](/filings/0001558370-20-003392.md) | [0.2](/filings/0001558370-21-003325.md) | [1.3](/filings/0001387131-22-003798.md) | [1.4](/filings/0001387131-23-003842.md) | [0.7](/filings/0001999371-24-003925.md) | [3.4](/filings/0001999371-25-002917.md) | [6.9](/filings/0001999371-26-005824.md) | [4.4](/filings/0001999371-26-005824.md) | [18.8](/filings/0001999371-26-005824.md) |
| Total assets | $m | not reported | [0.0](/filings/0001558370-19-002627.md) | [2,808](/filings/0001558370-20-003392.md) | [2,961](/filings/0001558370-21-003325.md) | [4,423](/filings/0001387131-22-003798.md) | [4,094](/filings/0001387131-23-003842.md) | [4,000](/filings/0001999371-24-003925.md) | [4,232](/filings/0001999371-25-002917.md) | [5,015](/filings/0001999371-26-005824.md) | [9,068](/filings/0001999371-26-005824.md) |
| Total liabilities | $m | not reported | not reported | [1.5](/filings/0001558370-20-003392.md) | [1.2](/filings/0001558370-21-003325.md) | [0.1](/filings/0001387131-22-003798.md) | [0.1](/filings/0001387131-23-003842.md) | [1.2](/filings/0001999371-24-003925.md) | [1.8](/filings/0001999371-25-002917.md) | [2.4](/filings/0001999371-26-005824.md) | [2.5](/filings/0001999371-26-005824.md) |
| Shareholders' equity | $m | [0.0](/filings/0001558370-19-002627.md) | [0.0](/filings/0001558370-20-003392.md) | [2,807](/filings/0001558370-21-003325.md) | [2,960](/filings/0001387131-22-003798.md) | [4,423](/filings/0001387131-23-003842.md) | [4,094](/filings/0001999371-24-003925.md) | [3,998](/filings/0001999371-25-002917.md) | [4,230](/filings/0001999371-26-005824.md) | [5,013](/filings/0001999371-26-005824.md) | [9,065](/filings/0001999371-26-005824.md) |

- Cash and equivalents: ifrs-full:CashAndCashEquivalents
- Total assets: ifrs-full:Assets
- Total liabilities: ifrs-full:Liabilities
- Shareholders' equity: ifrs-full:Equity

Shares outstanding: 190,937,369 at 2025-12-31, from the cover of the [40-F filed 2026-03-13](/filings/0001999371-26-005824.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:46 ET. No prices; not investment advice.